BIOGEN: EISAI TO REQUEST RECONSIDERATION OF DECISION WITHIN 90 DAYS TO MAKE LECANEMAB AVAILABLE FOR ELIGIBLE PEOPLE LIVING WITH EARLY AD IN AUSTRALIA

Reuters · 10/17 05:19

Please log in to view news